Join to View Full Profile
200 Medical Plaza, Suite B265Los Angeles, CA 90095
Phone+1 310-825-9775
Fax+1 310-825-9775
Dr. Nickols is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Radiation Oncology, 2010 - 2014
University of California (Irvine)Internship, Internal Medicine, 2009 - 2010
David Geffen School of Medicine at UCLAClass of 2009
Certifications & Licensure
CA State Medical License 2010 - 2026
American Board of Radiology Radiation Oncology
Clinical Trials
- Systemic and Tumor-Directed Therapy for Oligometastatic Prostate Cancer Start of enrollment: 2018 Jul 01
- Antiandrogen Therapy and SBRT in Treating Patients With Recurrent, Metastatic Prostate Cancer Start of enrollment: 2021 Mar 17
Publications & Presentations
PubMed
- Kinetics of PSMA PET signal after radiotherapy in prostate cancer lesions: A single-center retrospective study.Masatoshi Hotta, Kathleen Nguyen, Pan Thin, Wesley R Armstrong, Ida Sonni
Radiotherapy and Oncology. 2025-03-22 - Leveraging Radiotherapy Data for Precision Oncology: Veterans Affairs Granular Radiotherapy Information Database.Evangelia Katsoulakis, Cecelia J Madison, Rishabh Kapoor, Ryan A Melson, Anthony Gao
JCO Clinical Cancer Informatics. 2025-02-01 - 3 citationsPSMA-PET/CT Findings in Patients With High-Risk Biochemically Recurrent Prostate Cancer With No Metastatic Disease by Conventional Imaging.Adrien Holzgreve, Wesley R Armstrong, Kevyn J Clark, Matthias R Benz, Clayton P Smith
JAMA Network Open. 2025-01-02
Press Mentions
Three UCLA/VA Researchers to Be Honored by Secretary of Veterans AffairsMay 4th, 2023- ‘STARPORT’ Trial Probes New Approach for Aggressive Prostate CancerAugust 16th, 2021
Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical TrialJune 1st, 2019- Join now to see all
Grant Support
- Phase II Trial of targeted Radiation with no castration for mcrpc (POTENT-C)VA GREATER LOS ANGELES HEALTHCARE SYSTEM2024–2028
- Predicting Metastatic Progression of High Risk Localized Prostate CancerVA GREATER LOS ANGELES HEALTHCARE SYSTEM2023–2027
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
